Abstract
Corticotropin-releasing hormone (CRH) is a hypothalamic neuropeptide involved in the neuroendocrine response to stress, also playing a role in cell mediated immune functions. The aim of this study was to determine the circulating in the serum CRH levels in women with endometriosis and investigate the effect of the routinely 6-month administered treatment of danazol or leuprorelin acetate depot on these hormonal levels. Serum CRH levels were not significantly different in women with endometriosis and in the control group. The 6-month danazol or leuprorelin treatment had no effect on the levels of CRH. Three months after danazol treatment CRH levels were significantly lower (p < 0.005) than those before treatment. In contrast, after treatment with leuprorelin, CRH levels were significantly higher (p < 0.001). Our results suggest that endometriosis is not associated with CRH and that danazol as well as leuprorelin acetate depot have no effect on these levels during the treatment-specific period. However, they both showed significant fluctuations after the administration of these compounds ceased.
This is a preview of subscription content, log in via an institution to check access.
REFERENCES
American Fertility Society. (1985). Revised American Fertility Society classification of endometrio-sis, Fertil. Steril. 43, 351–6.
Athanassakis, I. and Iconomidou, B. (1996). Cytokine production in the serum and spleen of mice from day 6 to 14 of gestation, Dev. Immunol. 4, 247–55.
Athanassakis, I., Farmakiotis, V., Aifantis, I., et al. (1999). Expression of corticotrophin-releasing hormone in the mouse uterus: Participation in embryo implantation, J. Endocrinol. 163, 221–7.
Badawy, S. Z., Cuensa, V., Stritzel, A., et al. (1984). Autoimmune phenomena in infertile patients with endometriosis, Obstet. Gynecol. 63, 271–5.
Clifton, V. L., Tefler, J. F., Thompson, A. J., et al. (1998). Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium, J. Clin. Endocrinol. Metab. 83, 3716–21.
DiBlasio, A. M., Giraldi, F. P., Vigano, P., et al. (1997). Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stroma cells, J. Clin. Endocrinol. Metab. 82, 1594–7.
Dmowski, W. P., Steele, R. W. and Baker, G. F. (1981). Deficient cellular immunity in endometriosis, Am. J. Obstet. Gynecol. 142, 37–83.
Florio, P., Busacca, M., Vignali, M., et al. (1998). Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometri-otic women, J. Endocrinol. Invest. 21, 37–42.
Ho, H. N., Wu, M. Y. and Yang, Y. S. (1997). Peritoneal cellular immunity and endometriosis, Am. J. Reprod. Immunol. 38, 400–12.
Koninckx, T. K., Kennedy, S. H. and Barlow, D. H. (1998). Endometriotic disease: the role of peritoneal fluid, Hum. Reprod. Update 4, 741–51.
Matalliotakis, I., Neonaki, M., Zolindaki, A., et al. (1997). Changes in immunologic variables (TNF-α, sCD8 and sCD4) during danazol treatment in patients with endometriosis, Int. J. Fertil. Womens Med. 42, 211–4.
Panidis, D. K. and Matalliotakis, I. M. (1998). Subfertility associated with minimal to mild en-dometriosis. Main mechanisms, J. Reprod. Med. 43, 1034–42.
Sakata, M., Ohtsuka, S., Kurachi, H., et al. (1994). The hypothalamic-pituitary-ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol, Fertil. Steril. 61, 432–7.
Sizonenko, P. C. (1986). Hypothalamic factors: current findings, Schweiz Med. Wochenschr. 116, 271–4.
Wilson, E. E., Little, B. B., Byrd, W., et al. (1993). The effect of gonadotropin-releasing hormone agonists on adrenocorticotropin and cortisol secretion in adult premenopausal women, J. Clin. Endocrinol. Metab. 76, 162–4.
Wu, M. H., Yang, B. C., Hsu, C. C., et al. (1998). The expression of soluble intracellular adhesion molecule-1 in endometriosis, Fertil. Steril. 70, 1139–42.
Zoumakis, E., Margioris, A. N., Makrigiannakis, A., et al. (1997). Human endometrium as a neuroendocrine tissue: Expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides, J. Endocrinol. Invest. 20, 158–67.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matalliotakis, I.M., Athanassakis, I., Goumenou, A.G. et al. The anti-inflammatory action of danazol and leuprorelin acetate depot on endometriosis is CRH independent. Inflammopharmacology 9, 249–255 (2001). https://doi.org/10.1163/156856001760209798
Issue Date:
DOI: https://doi.org/10.1163/156856001760209798